MyCardium AI Becomes Approved Constellia Partner, Expanding Access for NHS and Public Sector

MyCardium is proud to announce that we are now an Approved Partner with Constellia, a leading neutral vendor for professional services. This milestone marks another important step in our mission to make clinically trusted, AI-driven cardiac imaging solutions more accessible to healthcare providers across the public sector.

Following our recent FDA 510(k) clearance and CE marking, this partnership further reinforces Mycarduim’s credibility as a trusted, compliant, and accessible partner for healthcare institutions seeking to modernise their cardiovascular imaging workflows.

Enabling Faster, Simpler Procurement for NHS Trusts

Constellia provides a compliant and efficient route for public sector organisations, including NHS Trusts, to access specialist suppliers. As an Approved Partner, MyCardium can now be engaged more easily and quickly, removing traditional procurement barriers and enabling faster adoption of advanced cardiac imaging technologies.

This ensures NHS organisations can confidently access our AI-powered solutions through a trusted and pre-approved framework, accelerating their ability to deploy tools that improve efficiency, consistency, and clinical confidence.

Supporting the Public Sector with Trusted, Clinically- Focused AI

Mycarduim’s platform is designed to support clinicians by reducing cognitive load, improving reproducibility, and accelerating reporting workflows, all while maintaining the highest standards of clinical accuracy and regulatory compliance.

Our solutions are:

• FDA 510(k) cleared and CE marked
• Built with direct clinician input and real-world validation
• Designed to integrate seamlessly into existing clinical workflows
• Delivered through a secure, zero-footprint deployment model

Becoming an Approved Constellia Partner demonstrates our continued commitment to meeting the operational, clinical, and governance needs of public healthcare providers.

Strengthening Our Commitment to NHS Innovation

The NHS faces increasing demand for cardiovascular imaging, alongside growing pressure to deliver faster diagnoses and improve operational efficiency. AI-enabled tools like MyCardium AI can play a critical role in helping healthcare providers scale their services while maintaining quality and consistency.

Through Constellia, NHS Trusts and public bodies can now engage MyCardium AI with confidence, knowing they are working with a vetted, compliant, and trusted technology partner.

This partnership represents another step forward in our mission to support clinicians and healthcare systems with AI solutions that make cardiac imaging faster, more reproducible, and more accessible.